Coronary artery disease

Transforming complex PCI procedures into confident care

Philips coronary suite has advanced clinical and workflow applications, therapeutic and diagnostic devices, and leading services, all working together to efficiently support every step of coronary procedures. From diagnosis to restoring vessel patency, the coronary suite ecosystem is designed to enhance performance and efficiency today, while serving as your launching pad to the future.   

Interventional cathlab

Improving lab performance while focusing on the patient

We recognize that the cath lab is a complex landscape, made up of different information and systems. Philips offers a fully integrated ecosystem designed to meet today’s challenges and can provide you with more information faster. This enhances cath lab performance and which ultimately can support confident decisions and exceptional patient care. Our CAD solutions work together to help you provide quick, confident diagnosis, along with effective, efficient treatment – ultimately contributing to improved outcomes.

Azurion performing PCI procedure on a patient

Azurion

Experience the new world of interventional cardiac and vascular performance with the Azurion 7 series with 12'' flat detector. 

Dynamic Coronary Roadmap

Dynamic Coronary Roadmap

Automatic, real-time navigational guidance designed for procedure efficiency in complex PCI interventions without changing current standard workflow.

Intra sight

IntraSight

The IntraSight applications platform is where imaging, physiology, co-registration1 and software all come together to clearly identify coronary and peripheral artery disease, and allow for more optimized treatment plans.

Technologies and innovations

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

Footnotes
 

[1] Co-registration tools available within IntraSight 7 configuration via SyncVision.

[2] Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decisionmaking.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.

[3] Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. iFR-SWEDEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017;376:1813-1823.

[4] Davies JE, Sen S, Dehbi HM, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017;376: 1824-1834.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

Olete sisenemas Philips HealthCare Eesti veebilehele.
Please select the checkbox

Veebilehel esitatud teave on mõeldud ainult isikutele, kes kasutavad meditsiiniseadmeid oma majandus- ja kutsetegevuses, sealhulgas tervishoiutöötajatele, tervishoiuteenuse osutajate esindajatele ning meditsiiniseadmetega oma majandus- ja kutsetegevuse raames kauplevatele isikutele. Veebilehel esitatud teave ei ole mõeldud meditsiiniliste nõuannete, ravijuhiste ega mistahes muude tervishoiualaste soovituste või suuniste andmiseks.

Kas olete isik, kes vastab ülaltoodud kriteeriumidele?